Moleculin Biotech, Inc. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Moleculin Biotech, Inc. stock issued during period, shares, new issues for the quarter ending 2022-09-30 was 21.12K shares.
- Moleculin Biotech, Inc. stock issued during period, shares, new issues for the quarter ending 2022-06-30 was 28.37K shares.
- Moleculin Biotech, Inc. stock issued during period, shares, new issues for the quarter ending 2022-03-31 was 0.00 shares.
- Moleculin Biotech, Inc. stock issued during period, shares, new issues for the quarter ending 2016-03-31 was 128.83K shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2022-09-30 | 21.12K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | |
| 2022-06-30 | 28.37K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | |
| 2022-03-31 | 0.00 shares 10-Q · filed 2022-05-11 | |
| 2016-03-31 | 128.83K shares 10-Q · filed 2016-06-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |